Komori
Daito Chemix (4366) · RiskRestated

Risk of increased investments in affiliates and failure to achieve expected results

First written in FY2020. 11 of 12 entries say "Restated". Latest entry: FY2026-H1.

12entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020 – FY2026-H12020: 320202021: 220212022: 320222023: 220232024: 120242025: 12025
Same theme, other companies
Risk of Failure to Achieve Results and Recover Investments in M&A, Investment and Financing, and Business AlliancesA theme 184 companies write about · 192 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 28 of 84 companies on the "Worse" side.

88 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 184 companies compared. The sentences above are computed from all 184.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「During the interim consolidated accounting period, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  2. FY2024-Q3RestatedAnnual report

    「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  3. FY2023RestatedAnnual report

    「当社は、経営資源を有効活用し、収益基盤の多様化を進めるため複数の関係会社を有しております。」

    関係会社への投資拡大、期待成果未達、関係会社株式評価損のリスクを継続している。
  4. FY2023-Q3RestatedAnnual report

    「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  5. FY2023-Q2RestatedAnnual report

    「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  6. FY2023-Q1RestatedAnnual report

    「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  7. FY2022-Q3RestatedAnnual report

    「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  8. FY2022-Q1RestatedAnnual report

    「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  9. FY2021-Q3RestatedAnnual report

    「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  10. FY2021-Q2RestatedAnnual report

    「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  11. FY2021-Q1RestatedAnnual report

    「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    関係会社への投資拡大および期待成果未達に関するリスクについて、新たな発生や重要な変更はないとしている。
  12. FY2020First statedAnnual report

    「当社は、経営資源を有効活用し、収益基盤の多様化を進めるため複数の関係会社を有しております。これらの関係会社は、今後の事業展開によって投資額が膨らむ可能性があります。また、経済環境の変化によっては、期待した成果が得られる保証はなく、当社グループの業績および財務状況に影響を及ぼす可能性があります。」

    関係会社への投資額が膨らむ可能性、期待した成果が得られない可能性、個別財務諸表で関係会社株式の評価損が発生する可能性を新たなリスクとして記載している。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Daito Chemix's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of increased investments in affiliates and failure to achieve expected results | Daito Chemix Corporation (4366) | Komori